Company Filing History:
Years Active: 2017-2025
Title: Tetsu Sugimura: Innovator in Immunology
Introduction
Tetsu Sugimura is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of immunology, particularly through his innovative work involving lactic acid bacteria. With a total of four patents to his name, Sugimura's inventions focus on enhancing immune responses and providing prophylactic solutions against viral infections.
Latest Patents
One of Sugimura's latest patents is an agent for inducing interferon production that contains lactic acid bacteria. This invention provides an interferon (IFN) inducer comprising lactic acid bacteria as an active ingredient, which is capable of inducing IFN production. The invention also includes an immunopotentiating agent or prophylactic agent against virus infection that comprises such an inducer. Additionally, it encompasses food or drink products that contain this IFN inducer and exhibit IFN-inducing activity, immunopotentiating activity, or prophylactic activity against viral infections. The active ingredients in this agent are lactic acid bacteria that can activate plasmacytoid dendritic cells (pDCs) and promote IFN production, including strains such as NBRC100934, subsp. JCM16167, and others.
Career Highlights
Tetsu Sugimura is currently associated with Kirin Holdings Kabushiki Kaisha, a prominent company in the food and beverage industry. His work at Kirin has allowed him to explore the intersection of nutrition and immunology, leading to groundbreaking inventions that have the potential to improve public health.
Collaborations
Sugimura has collaborated with notable colleagues such as Daisuke Fujiwara and Kenta Jonai. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of immunology.
Conclusion
Tetsu Sugimura's contributions to the field of immunology through his innovative patents highlight the importance of research in enhancing immune responses. His work continues to pave the way for new solutions in the fight against viral infections.